Bantam Pharmaceuticals
Clinical trials sponsored by Bantam Pharmaceuticals, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cancer drug BTM-3566 enters first human tests Results expected Feb 2027 (estimated)
- New pill BTM-3566 takes on tough lymphoma in early trial Results expected Feb 2027 (estimated)
-
New pill BTM-3566 takes on tough lymphoma in early trial
Disease control Recruiting nowThis early-phase trial is testing an oral drug called BTM-3566 in 24 adults with relapsed or refractory B-cell lymphoma. The main goals are to find a safe dose and see if the drug can slow or stop the cancer. Participants take the drug for 7 days, then have 7 days off, and visit …
Phase 1 • Sponsor: Bantam Pharmaceuticals • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New cancer drug BTM-3566 enters first human tests
Disease control Recruiting nowThis early-stage trial is testing a new drug called BTM-3566 in 30 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find safe doses and understand side effects. Participants take the drug for 7 days on and 7 days off, and res…
Phase 1 • Sponsor: Bantam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC